09 April 2020

Equilibar focusing on ventilator valves while continuing regular projects

By Jeff Jennings – also posted on www.equilibar.com – for future updates, please bookmark the Equilibar COVID-19 VENTILATOR VALVES PAGE

Important update: After months of intense research and development efforts, Equilibar announced on June 9 that the US Food and Drug Administration had granted Emergency Use Authorization for the BioMedInnovations (BMI) SuppleVent™, a ventilator system that utilizes Equilibar® patented back pressure regulator technology.

equilibar technology update

I wanted to tell you firsthand about our recent focus on helping to find solutions for the worldwide ventilator shortage due to COVID-19 and explain how we are continuing our regular work in existing markets.

On March 20, we received the first inquiry about modifying Equilibar technology to provide pressure control for ventilator systems. Since the existing supply chain used to manufacture ventilators has been disrupted, technical teams around the world are working to find alternative components as quickly and efficiently as possible. After initial discussions and investigations, I decided that joining this effort was a realistic and appropriate endeavor for our team.

For the past few weeks, we have worked days, nights and weekends and have accomplished more than I ever could have imagined. We have partnered with multiple biomedical experts and have released several new products specifically designed for ventilator systems. These are in various stages of testing and validations. If you’re curious, I hope you will visit our dedicated COVID-19 VENTILATOR VALVES UPDATES page, which has product cutsheets, videos, schematics and more.

I always find it gratifying to work with innovators around the world, but I consider it a special privilege to be working on this project with a true North Carolina legend. Roush Yates Engines and Roush Yates Manufacturing of NASCAR racing fame are machining and assembling our valves in volume to provide them to the world as quickly and affordably as possible. They are tabling their state-of-the-art racing projects to focus on this humanitarian need, and we are deeply appreciative.

I am grateful for several serendipitous choices that have allowed Equilibar to continue our existing work while accepting a greater challenge. Our decision last year to expand our engineering and production teams has enabled us to have a full bench of talent to multi-task as needed. Our new engineers and technicians are up to speed and in sync. Plus, they have brought us skillsets that we didn’t have before and didn’t necessarily even know we needed until now.

Thanks to the proactive decision of David Reed, vice president for operations, we had split-shift and work-from-home plans in place before most companies were even considering the idea. Things have gone as smoothly as possible.

Finally, by using Roush Yates for this temporary surge in production, we can continue to use our long-time local partners to machine our existing products in a timely and professional way.

I am thankful to our partners and vendors who are working hard to help us meet our commitments. Most of all, I am thankful for the entire Equilibar team. Each person’s job is important in helping us contribute to this worldwide endeavor and even thrive while we’re doing it.

I’d like to end by saying that I am optimistic. The level of innovation, energy and collaboration that I have witnessed these past few weeks makes it impossible to be anything else. At the same time, I recognize the gravity of the pandemic and sincerely hope that all our customers, partners and team members stay healthy and safe. We send you all best wishes.

If you have any questions or comments about the ventilator valves or our fluid control technology in general, please contact one of our application engineers at [email protected]. They look forward to hearing from you.

Copyright © 2020 Equilibar, All rights reserved.